Tetratherix Limited (ASX:TTX)
Australia · Delayed Price · Currency is AUD 6.93
+0.50 (7.78%)
Aug 28, 2026, 3:59 PM AEST
Tetratherix Market Cap
Tetratherix has a market cap or net worth of 367.54 million as of August 28, 2026. Its market cap has increased by 78.11% in one year.
Market Cap
367.54M
Enterprise Value
344.14M
Revenue
3.86M
Ranking
n/a
PE Ratio
n/a
Stock Price
6.93
ChartMarket Cap Chart
Since June 30, 2025, Tetratherix's market cap has increased from 152.00M to 367.54M, an increase of 141.80%. That is a compound annual growth rate of 113.84%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 28, 2026 | 367.54M | 122.63% |
| Dec 30, 2025 | 165.09M | 8.61% |
| Jun 30, 2025 | 152.00M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Clarity Pharmaceuticals | 873.01M |
| Clinuvel Pharmaceuticals | 462.93M |
| Racura Oncology | 431.35M |
| Starpharma Holdings | 345.86M |
| BLS Pharmaceuticals | 213.88M |
| Orthocell | 212.36M |
| Nyrada | 182.85M |
| Dimerix | 174.12M |